<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">−/− </span>
   <span class="font21">YFV </span>
   <span class="font20">results </span>
   <span class="font17">laboratories </span>
   <span class="font16">RT-PCR </span>
   <span class="font16">samples </span>
   <span class="font16">nd/− </span>
   <span class="font15">serological </span>
   <span class="font15">detection </span>
   <span class="font15">IIF </span>
   <span class="font14">diagnosis </span>
   <span class="font14">OPTIMAL </span>
   <span class="font14">IgG </span>
   <span class="font14">TaqMan </span>
   <span class="font14">reported </span>
   <span class="font14">sample </span>
   <span class="font14">−/nd </span>
   <span class="font14">NON </span>
   <span class="font14">using </span>
   <span class="font13">EQA </span>
   <span class="font13">IgM </span>
   <span class="font13">laboratory </span>
   <span class="font13">used </span>
   <span class="font13">presence </span>
   <span class="font13">antibodies </span>
   <span class="font13">molecular </span>
   <span class="font13">(%) </span>
   <span class="font13">virus </span>
   <span class="font13">assays </span>
   <span class="font13">fever </span>
   <span class="font12">Table </span>
   <span class="font12">performance </span>
   <span class="font12">methods </span>
   <span class="font12">PCR </span>
   <span class="font12">diagnostic </span>
   <span class="font12">different </span>
   <span class="font12">real-time </span>
   <span class="font12">sensitivity </span>
   <span class="font12">However, </span>
   <span class="font12">positive </span>
   <span class="font12">viral </span>
   <span class="font12">false </span>
   <span class="font12">genome </span>
   <span class="font11">ELISA </span>
   <span class="font11">negative </span>
   <span class="font11">&amp;lt;∶ </span>
   <span class="font11">Virol </span>
   <span class="font11">assay </span>
   <span class="font11">containing </span>
   <span class="font11">flaviviruses </span>
   <span class="font11">good </span>
   <span class="font11">nd/ </span>
   <span class="font11">obtained </span>
   <span class="font11">specific </span>
   <span class="font11">strain </span>
   <span class="font11">use </span>
   <span class="font11">wild-type </span>
   <span class="font11">Clin </span>
   <span class="font11">dengue </span>
   <span class="font11">infection </span>
   <span class="font11">strains </span>
   <span class="font11">study </span>
   <span class="font11">test </span>
   <span class="font11">yellow </span>
   <span class="font11">anti-YFV </span>
   <span class="font11">included </span>
   <span class="font11">quality </span>
   <span class="font11">specificity </span>
   <span class="font11">PANFLAV </span>
   <span class="font11">YFV-D </span>
   <span class="font11">Yellow </span>
   <span class="font11">cases </span>
   <span class="font11">control </span>
   <span class="font11">diagnostics </span>
   <span class="font11">dilutions </span>
   <span class="font11">false-positive </span>
   <span class="font11">protocols </span>
   <span class="font11">techniques </span>
   <span class="font11">"in-house" </span>
   <span class="font11">Dis </span>
   <span class="font11">Drosten </span>
   <span class="font11">GE/sample </span>
   <span class="font11">West </span>
   <span class="font11">considered </span>
   <span class="font11">data </span>
   <span class="font11">detect </span>
   <span class="font11">did </span>
   <span class="font11">flavivirus </span>
   <span class="font11">need </span>
   <span class="font11">nested </span>
   <span class="font11">participants </span>
   <span class="font11">sera </span>
   <span class="font11">/nd </span>
   <span class="font11">African </span>
   <span class="font11">EQA, </span>
   <span class="font11">Microbiol </span>
   <span class="font11">Network </span>
   <span class="font11">Niedrig </span>
   <span class="font11">RT-nested </span>
   <span class="font11">South </span>
   <span class="font11">achieved </span>
   <span class="font11">analysis </span>
   <span class="font11">case </span>
   <span class="font11">commercial </span>
   <span class="font11">correct </span>
   <span class="font11">disease </span>
   <span class="font11">infections </span>
   <span class="font11">no. </span>
   <span class="font11">panel </span>
   <span class="font11">plasma </span>
   <span class="font11">reports </span>
   <span class="font11">results, </span>
   <span class="font11">seroneutralization </span>
   <span class="font11">sets </span>
   <span class="font11">showed </span>
   <span class="font10">Africa </span>
   <span class="font10">Bae </span>
   <span class="font10">Coast </span>
   <span class="font10">Domingo </span>
   <span class="font10">IgM/IgG/ </span>
   <span class="font10">Infect </span>
   <span class="font10">Institute </span>
   <span class="font10">Ivory </span>
   <span class="font10">Methods </span>
   <span class="font10">RNA </span>
   <span class="font10">Viral </span>
   <span class="font10">better </span>
   <span class="font10">diagnosis. </span>
   <span class="font10">dilution </span>
   <span class="font10">failed </span>
   <span class="font10">general, </span>
   <span class="font10">laboratory. </span>
   <span class="font10">participated </span>
   <span class="font10">participating </span>
   <span class="font10">positives </span>
   <span class="font10">report </span>
   <span class="font10">result </span>
   <span class="font10">serial </span>
   <span class="font10">tests </span>
   <span class="font10">(.%) </span>
   <span class="font10">(n = ), </span>
   <span class="font10">(n = , </span>
   <span class="font10">American </span>
   <span class="font10">European </span>
   <span class="font10">Germany; </span>
   <span class="font10">Health </span>
   <span class="font10">IgM/IgG−/− </span>
   <span class="font10">National </span>
   <span class="font10">ab, </span>
   <span class="font10">accuracy </span>
   <span class="font10">acute </span>
   <span class="font10">applied </span>
   <span class="font10">approach </span>
   <span class="font10">concentration </span>
   <span class="font10">confirm </span>
   <span class="font10">described </span>
   <span class="font10">difference </span>
   <span class="font10">effect </span>
   <span class="font10">flaviviruses. </span>
   <span class="font10">higher </span>
   <span class="font10">identification </span>
   <span class="font10">inactivated </span>
   <span class="font10">load </span>
   <span class="font10">main </span>
   <span class="font10">mainly </span>
   <span class="font10">method </span>
   <span class="font10">number </span>
   <span class="font10">performed </span>
   <span class="font10">previous </span>
   <span class="font10">previously </span>
   <span class="font10">profile </span>
   <span class="font10">protocol </span>
   <span class="font10">provide </span>
   <span class="font10">quantitative </span>
   <span class="font10">results. </span>
   <span class="font10">samples. </span>
   <span class="font10">serum </span>
   <span class="font10">techniques. </span>
   <span class="font10">time </span>
   <span class="font10">versus </span>
   <span class="font10">(score </span>
   <span class="font10">-fold </span>
   <span class="font10">DENV- </span>
   <span class="font10">Detection </span>
   <span class="font10">Diseases </span>
   <span class="font10">Europe </span>
   <span class="font10">HG, </span>
   <span class="font10">Institut </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Logit </span>
   <span class="font10">Molecular </span>
   <span class="font10">NEG </span>
   <span class="font10">Similarly, </span>
   <span class="font10">University </span>
   <span class="font10">YFV, </span>
   <span class="font10">[WHO] </span>
   <span class="font10">assays. </span>
   <span class="font10">assessment </span>
   <span class="font10">controls </span>
   <span class="font10">cross-reactivity </span>
   <span class="font10">depending </span>
   <span class="font10">endemic </span>
   <span class="font10">eq/− </span>
   <span class="font10">estimate </span>
   <span class="font10">estimated </span>
   <span class="font10">evaluation </span>
   <span class="font10">expected </span>
   <span class="font10">infections. </span>
   <span class="font10">international </span>
   <span class="font10">major </span>
   <span class="font10">neg </span>
   <span class="font10">order </span>
   <span class="font10">performing </span>
   <span class="font10">points </span>
   <span class="font10">recent </span>
   <span class="font10">risk </span>
   <span class="font10">set </span>
   <span class="font10">seven </span>
   <span class="font10">suitable </span>
   <span class="font10">taken </span>
   <span class="font10">total </span>
   <span class="font10">vaccine </span>
   <span class="font10">virus, </span>
   <span class="font10">αYFD </span>
  </p>
 </body>
</html>
